Related Experiment Video
Updated: Jul 15, 2025

Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma
Published on: September 20, 2024
Evaluating interleukin-6 levels and the rs1800795 variant in Turkish patients with COVID-19: a prospective cohort
Ozlem Sezer1, Ayse Feyda Nursal2, Ozgur Gunal3
1Department of Medical Genetics, Faculty of Medicine, Samsun University, Samsun, Turkey.
Insights
The interleukin 6 (IL6) rs1800795 variant is associated with COVID-19 susceptibility in Turkish patients. Higher frequencies of the IL6 rs1800795 GG genotype and G allele were observed in positive cases and asymptomatic individuals.
Area of Science:
- Genetics
- Immunology
- Infectious Diseases
Background:
- Coronavirus disease 2019 (COVID-19) is a significant multisystem illness.
- Interleukin-6 (IL-6) is a key cytokine influencing inflammation and immune responses.
Purpose of the Study:
- To investigate the association between the interleukin 6 (IL6) rs1800795 genetic variant and IL-6 levels in Turkish COVID-19 patients.
- To explore the correlation of this variant with disease severity and clinical presentation.
Main Methods:
- A prospective cohort study involving 148 real-time RT-PCR and/or CT-confirmed COVID-19 patients.
- IL6 rs1800795 genotyping using PCR-RFLP and serum IL-6 measurement via ELISA.
- Patients were categorized into asymptomatic, symptomatic, and intensive care unit groups.
Main Results:
- Increased IL6 rs1800795 GG genotype and G allele frequencies were found in PCR-positive patients compared to PCR-negative individuals (p < 0.000).
- The GG genotype and G allele were more prevalent in asymptomatic patients and CT-negative patients.
- Elevated serum IL-6 levels were observed in asymptomatic patients.
Conclusions:
- The IL6 rs1800795 variant may play a role in COVID-19 susceptibility among individuals of Turkish descent.
- Further large-scale studies across diverse genetic populations are warranted to validate these findings.
Background:
Coronavirus disease 2019 (COVID-19) is a multisystem disease of global significance. Interleukin (IL)-6 is a soluble cytokine with a pleiotropic effect on inflammation and the immune response.
Objectives:
Investigate the relationship between the interleukin 6 (IL6) rs1800795 variant and IL6 level in Turkish patients with COVID-19 disease.
Design:
Prospective cohort study.
Setting:
Tertiary care hospital.
Patients And Methods:
Real-time polymerase chain reaction (RT-PCR)-positive and/or chest computerized tomography (CT) scancompatible COVID-19 patients were enrolled in the study. The clinical data and whole blood samples were collected from April 1, 2020, to August 1, 2020. IL6 rs1800795 genotyping was performed by the PCR-restriction fragment-length polymorphism (RFLP) method in 148 patients. Serum IL-6 concentrations were measured using the ELISA method in 89 patients. We evaluated the patients in three groups: asymptomatic, symptomatic, and intensive care unit patients.
Main Outcome Measures:
IL6 rs1800795 genotype frequencies and serum IL-6 levels in COVID-19 patients with different clinical presentations.
Sample Size:
148 cases.
Results:
IL6 rs1800795 GG genotype and G allele frequency increased in PCR positive patients compared to PCR-negative patients (p ˂ 0.000). IL6 rs1800795 GC genotype and C allele frequency were lower in PCR-positive patients than in PCR-negative patients. IL6 rs1800795 GG genotype and G allele frequency were higher in asymptomatic patients than in the symptomatic and intensive care unit groups. The IL6 rs1800795 C allele frequency was lower in asymptomatic patients than in the symptomatic and intensive care unit groups. IL6 rs1800795 GG genotype and G allele frequency were higher in CT negative patients than CT positive patients, while IL6 GC genotype and C allele frequency were higher in CT positive patients than negative patients. IL6 level elevation was seen in the asymptomatic patients compared to the symptomatic and intensive care unit groups.
Conclusions:
These findings suggest that IL6 rs1800795 may contribute to the susceptibility of COVID-19 in people to Turkish origin.
Limitations:
Further large-scale studies in different genetic populations are needed as this is a single-center, prospective study.
Related Concept Videos
Single Nucleotide Polymorphisms-SNPs
The JAK-STAT Signaling Pathway

